$GUER
Guerrilla RF Inc Stock $guer

$guer Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000143774923013411 Filed on May 10, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$3.779M	$3.231M
YoY Change	22.41%	-16.43%
Cost Of Revenue	$1.550M	$1.403M
YoY Change	21.3%	-9.3%
Gross Profit	$2.229M	$1.828M
YoY Change	23.2%	-21.18%
Gross Profit Margin	58.99%	56.56%
Selling, General & Admin	$3.007M	$2.908M
YoY Change	23.6%	25.05%
% of Gross Profit	134.89%	159.13%
Research & Development	$2.653M	$2.586M
YoY Change	31.54%	43.52%
% of Gross Profit	119.0%	141.51%
Depreciation & Amortization	$423.1K	$398.3K
YoY Change	52.9%	58.73%
% of Gross Profit	18.98%	21.8%
Operating Expenses	$5.660M	$5.494M
YoY Change	27.19%	33.11%
Operating Profit	-$3.431M	-$3.667M
YoY Change	29.93%	102.71%
Interest Expense	-$389.0K	-$341.9K
YoY Change	449.04%	497.43%
% of Operating Profit
Other Income/Expense, Net	-$390.3K	-$334.7K
YoY Change	286.0%	484.89%
Pretax Income	-$3.821M	-$4.001M
YoY Change	39.37%	114.43%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$3.800M	-$4.000M
YoY Change	40.74%	114.35%
Net Earnings / Revenue	-100.55%	-123.8%
Basic Earnings Per Share	-$0.56	-$0.62
Diluted Earnings Per Share	-$0.56	-$0.62
COMMON SHARES
Basic Shares Outstanding	6.797M	40.55M
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$238.0K	$1.878M
YoY Change	-86.04%	-27.53%
Cash & Equivalents	$238.0K	$1.878M
Short-Term Investments
Other Short-Term Assets	$738.5K	$770.2K
YoY Change	-2.97%	-26.03%
Inventory	$1.778M	$1.584M
Prepaid Expenses	$738.5K	$770.2K
Receivables	$1.985M	$1.596M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$4.740M	$5.828M
YoY Change	-24.83%	-26.05%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.882M	$4.984M
YoY Change	0.18%	20.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$197.1K	$90.08K
YoY Change
Total Long-Term Assets	$15.78M	$15.97M
YoY Change	208.2%	262.42%
TOTAL ASSETS
Total Short-Term Assets	$4.740M	$5.828M
Total Long-Term Assets	$15.78M	$15.97M
Total Assets	$20.52M	$21.80M
YoY Change	79.61%	77.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.466M	$2.374M
YoY Change	28.43%	68.54%
Accrued Expenses	$552.1K	$568.0K
YoY Change	364.6%	389.11%
Deferred Revenue
YoY Change
Short-Term Debt	$1.842M	$1.363M
YoY Change
Long-Term Debt Due	$1.125M	$1.092M
YoY Change	57.77%	63.17%
Total Short-Term Liabilities	$5.985M	$5.397M
YoY Change	51.61%	145.18%
LONG-TERM LIABILITIES
Long-Term Debt	$9.274M	$7.631M
YoY Change	228.76%	168.98%
Other Long-Term Liabilities	$6.277M	$6.389M
YoY Change	4722.91%	3877.2%
Total Long-Term Liabilities	$15.55M	$14.02M
YoY Change	426.98%	367.7%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.985M	$5.397M
Total Long-Term Liabilities	$15.55M	$14.02M
Total Liabilities	$21.54M	$19.42M
YoY Change	212.17%	273.48%
SHAREHOLDERS EQUITY
Retained Earnings	-$34.90M	-$31.10M
YoY Change	77.16%	84.02%
Common Stock	$679.00	$678.00
YoY Change	-79.57%	-79.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.013M	$2.381M
YoY Change
Total Liabilities & Shareholders Equity	$20.52M	$21.80M
YoY Change	79.61%	77.41%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$3.800M	-$4.000M
YoY Change	40.74%	114.35%
Depreciation, Depletion And Amortization	$423.1K	$398.3K
YoY Change	52.9%	58.73%
Cash From Operating Activities	-$3.095M	-$5.835M
YoY Change	75.11%	140.15%
INVESTING ACTIVITIES
Capital Expenditures	-$24.66K	$117.8K
YoY Change	-83.24%	-22.74%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$24.66K	-$117.8K
YoY Change	-116.76%	-22.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.431M	$3.490M
YoY Change	39.09%	-2575.18%
NET CHANGE
Cash From Operating Activities	-3.095M	-$5.835M
Cash From Investing Activities	24.66K	-$117.8K
Cash From Financing Activities	1.431M	$3.490M
Net Change In Cash	-1.640M	-$2.463M
YoY Change	85.07%	-9.57%
FREE CASH FLOW
Cash From Operating Activities	-$3.095M	-$5.835M
Capital Expenditures	-$24.66K	$117.8K
Free Cash Flow	-$3.071M	-$5.953M
YoY Change	89.49%	130.54%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6784721
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6784721
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6211206
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6211206
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0	usd
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0	usd
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	usd
CY2023Q1	guer	Common Stock Voting Rights Vote Per Share CommonStockVotingRightsVotePerShare	1	pure
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q1	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	0	usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	000-56238
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-3837067
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	2000 Pisgah Church Road
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Greensboro
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	27455
CY2023Q1	dei	City Area Code CityAreaCode	336
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	510-7840
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6797221
CY2023Q1	us-gaap	Cash Cash	1877568	usd
CY2022Q4	us-gaap	Cash Cash	4340407	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1595906	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1124971	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	1583915	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1672925	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	770232	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	643401	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	5827621	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	7781704	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	0	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	3574746	usd
CY2023Q1	guer	Deferred Offering Costs Noncurrent DeferredOfferingCostsNoncurrent	90081	usd
CY2022Q4	guer	Deferred Offering Costs Noncurrent DeferredOfferingCostsNoncurrent	0	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10896388	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	209669	usd
CY2023Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	4983918	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	5098097	usd
CY2023Q1	us-gaap	Assets Assets	21798008	usd
CY2022Q4	us-gaap	Assets Assets	16664216	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2374131	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4466045	usd
CY2023Q1	guer	Shortterm Debt And Longterm Debt Current Maturities ShorttermDebtAndLongtermDebtCurrentMaturities	1363186	usd
CY2022Q4	guer	Shortterm Debt And Longterm Debt Current Maturities ShorttermDebtAndLongtermDebtCurrentMaturities	959803	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	568000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	139794	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1092101	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1078506	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5397418	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6644148	usd
CY2023Q1	guer	Longterm Debt Noncurrent Excluding Longterm Notes Payable LongtermDebtNoncurrentExcludingLongtermNotesPayable	306511	usd
CY2022Q4	guer	Longterm Debt Noncurrent Excluding Longterm Notes Payable LongtermDebtNoncurrentExcludingLongtermNotesPayable	44279	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6388970	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	71714	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2737467	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2984618	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	4586852	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	4564564	usd
CY2023Q1	us-gaap	Liabilities Liabilities	19417218	usd
CY2022Q4	us-gaap	Liabilities Liabilities	14309323	usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	678	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	621	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	33454698	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	29427440	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-31074586	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27073168	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2380790	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2354893	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21798008	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16664216	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3230888	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3865911	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1403345	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1547281	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	1827543	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	2318630	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2586169	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1802006	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1361949	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1085843	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1546163	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1239650	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	5494281	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	4127499	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3666738	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1808869	usd
CY2023Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-341857	usd
CY2022Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-57221	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7177	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-334680	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-57221	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4001418	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1866090	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.62
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6502845
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5538034
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2354893	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4001418	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3658675	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	100000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	268640	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2380790	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	8915625	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1866090	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5232	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	32856	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	7087623	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4001418	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1866090	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	398321	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	250937	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	268640	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	32856	usd
CY2023Q1	us-gaap	Accretion Expense AccretionExpense	30763	usd
CY2022Q1	us-gaap	Accretion Expense AccretionExpense	0	usd
CY2023Q1	guer	Shares Issued For Prepaid Services SharesIssuedForPrepaidServices	20833	usd
CY2022Q1	guer	Shares Issued For Prepaid Services SharesIssuedForPrepaidServices	0	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	470935	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	942049	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-89010	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	200028	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-42005	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-146090	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1929785	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	148423	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-282820	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5835386	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2429861	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	117799	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	152464	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-117799	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-152464	usd
CY2023Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	2239320	usd
CY2022Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	usd
CY2023Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	3658675	usd
CY2022Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	0	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5232	usd
CY2023Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	1968784	usd
CY2022Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	-0	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	266862	usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	146246	usd
CY2023Q1	guer	Repayment Of Finance Insurance Premiums Financing Activities RepaymentOfFinanceInsurancePremiumsFinancingActivities	122003	usd
CY2022Q1	guer	Repayment Of Finance Insurance Premiums Financing Activities RepaymentOfFinanceInsurancePremiumsFinancingActivities	-0	usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	50000	usd
CY2022Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3490346	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-141014	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2462839	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2723339	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4340407	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5313985	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1877568	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2590646	usd
CY2023Q1	us-gaap	Stock Issued1 StockIssued1	100000	usd
CY2022Q1	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	165825	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	3127940	usd
CY2023Q1	guer	Financing Of Insurance Premium And Software FinancingOfInsurancePremiumAndSoftware	173360	usd
CY2022Q1	guer	Financing Of Insurance Premium And Software FinancingOfInsurancePremiumAndSoftware	0	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	7235222	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023Q1	guer	Financing Of Mask Set FinancingOfMaskSet	112728	usd
CY2022Q1	guer	Financing Of Mask Set FinancingOfMaskSet	0	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	518	usd
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	73810	usd
CY2023Q1	us-gaap	Nature Of Operations NatureOfOperations	<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b><em style="font: inherit;">1.</em> ORGANIZATION AND NATURE OF BUSINESS</b></p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt; text-align: justify;">Guerrilla RF, Inc. (formerly known as Laffin Acquisition Corp., the “Company”) was incorporated in the State of Delaware on <em style="font: inherit;"> November 9, 2020. </em>On <em style="font: inherit;"> October </em><em style="font: inherit;">22,</em> <em style="font: inherit;">2021,</em> the Company's wholly-owned subsidiary, Guerrilla RF Acquisition Corp., a corporation formed in the State of Delaware on <em style="font: inherit;"> October </em><em style="font: inherit;">20,</em> <em style="font: inherit;">2021</em> (“Acquisition Sub”) and privately held Guerrilla RF Operating Corporation (formerly known as Guerrilla RF, Inc.) entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”). Pursuant to the terms of the Merger Agreement, on <em style="font: inherit;"> October </em><em style="font: inherit;">22,</em> <em style="font: inherit;">2021</em> (the “Closing Date”), Acquisition Sub merged with and into Guerrilla RF Operating Corporation with Guerrilla RF Operating Corporation continuing as the surviving corporation and a wholly-owned subsidiary of the Company (the “Merger”). </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -9pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt; text-align: justify;">Prior to the Merger, Laffin Acquisition Corp. was a “shell” company registered under the Securities Exchange Act of <em style="font: inherit;">1934,</em> as amended (“the Exchange Act”), with <em style="font: inherit;">no</em> specific business plan or purpose until it began operating the business of Guerrilla RF Operating Corporation following the closing of the Merger.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -9pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt; text-align: justify;">All references in these unaudited interim condensed consolidated financial statements and related Quarterly Report to “Guerrilla RF” refer to Guerrilla RF Operating Corporation, our direct, wholly-owned subsidiary. Unless otherwise stated or the context otherwise indicates, references to the “Company”, “we”, “our”, “us” or similar terms refer to Guerrilla RF, Inc. (formerly known as Laffin Acquisition Corp.) together with its wholly-owned subsidiary, Guerrilla RF. Guerrilla RF holds all material assets and conducts all business activities and operations of the Company. Accordingly, throughout these unaudited interim consolidated financial statements and related Quarterly Report, there are frequent references to Guerrilla RF. </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Guerrilla RF designs and manufactures high‐performance Monolithic Microwave Integrated Circuits (MMICs) for the wireless infrastructure market. Guerrilla RF primarily focuses on researching and developing its existing products and building an infrastructure to handle a global distribution network; therefore, it has incurred significant start‐up losses. </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Merger was accounted for as a “reverse acquisition” since, immediately following the consummation of the Merger, Guerrilla RF effectively controlled the Company. For accounting purposes, Guerrilla RF was deemed to be the accounting acquirer in the Merger and, consequently, the Merger is treated as a recapitalization of Guerrilla RF (i.e., a capital transaction involving the issuance of shares by the Company for the shares of Guerrilla RF). Accordingly, the assets, liabilities, and results of operations of Guerrilla RF became the historical consolidated financial statements of the Company, and the Company’s assets, liabilities, and results of operations were consolidated with Guerrilla RF beginning at the Closing Date. <em style="font: inherit;">No</em> step-up in basis or intangible assets or goodwill were recorded in the Merger.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Liquidity and Going Concern</b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt; text-align: justify;">In accordance with Financial Accounting Standards (“FASB”) Accounting Standards Update (“ASU”) <i><em style="font: inherit;">No.</em></i> <i><em style="font: inherit;">2014</em></i>-<i><em style="font: inherit;">15,</em> Disclosure of Uncertainties about an Entity</i>’<i>s Ability to Continue as a Going Concern (Subtopic</i> <i><em style="font: inherit;">205</em>-<em style="font: inherit;">40</em>)</i>, the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within <em style="font: inherit;">one</em> year after the date that the unaudited interim condensed consolidated financial statements are issued. The accompanying unaudited interim condensed consolidated financial statements have been presented on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the ordinary course of business. The Company has historically financed its activities principally from common and preferred equity securities and debt issuances.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: left;"/> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The accompanying unaudited interim consolidated financial statements have been presented on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the ordinary course of business. The Company has historically financed its activities principally from common and preferred equity securities and debt issuance. <span style="background-color:#ffffff">The unaudited interim condensed consolidated financial statements do <em style="font: inherit;">not</em> include any adjustments relating to the recoverability of the recorded assets or the classification of liabilities that <em style="font: inherit;"> may </em>be necessary should the Company be unable to continue as a going concern.</span></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company has incurred substantial negative cash flows from operations in nearly every fiscal period since inception, <span style="font-family:"Times New Roman"; font-size:10pt"><span style="background-color:#ffffff">including a </span></span><span style="font-family:"Times New Roman"; font-size:10pt"><span style="background-color:#ffffff;">net loss of $4.0 million for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> March 31, 2023</em></span></span><span style="background-color:#ffffff;">. In addition, as of <em style="font: inherit;"> March 31, 2023, </em>the Company had an accumulated deficit o</span><span style="font-family:"Times New Roman"; font-size:10pt"><span style="background-color:#ffffff;">f $31.1 million</span></span><span style="font-family:"Times New Roman"; font-size:10pt"><span style="background-color:#ffffff;">.</span></span><span style="background-color:#ffffff;"> The Company expects losses and negative cash flows to continue, primarily as a result of continued investment in research and development, capital additions supporting our planned business expansion and growth, sales and marketing efforts, </span>and increased administration expenses as our Company grows<span style="background-color:#ffffff">. </span>We plan to continue to invest in the implementation of our long-term strategic plan and we will require additional funding in <em style="font: inherit;">2023.</em> There is <em style="font: inherit;">no</em> assurance that appropriate funding will be available on terms, which are acceptable to us, or at all. This requirement for additional funding raises substantial doubt about our ability to continue as a going concern.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><span style="background-color:#ffffff;">The Company had a cash balance of $1.9 million at <em style="font: inherit;"> March 31, 2023. </em>In <em style="font: inherit;"> June 2022, </em>the Company established a loan facility with Spectrum Commercial Services Company, L.L.C. ("Spectrum") providing for advances of up to $3.0 million (the "Spectrum Loan Facility" further described in Note <em style="font: inherit;">5</em>). As of <em style="font: inherit;"> March 31, 2023, </em>the outstanding balance under the Spectrum Loan Facility was $1.0 million. In <em style="font: inherit;"> August </em><em style="font: inherit;">2022,</em> the Company established a loan facility with Salem Investment Partners V, Limited Partnership ("Salem") providing for advances of up to $8.0 million (the "Salem Loan Facility" further described in Note <em style="font: inherit;">5</em>). As of <em style="font: inherit;"> March 31, 2023, </em>the undiscounted outstanding balance under the Salem Loan Facility was $5.0 million.</span></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company raised gross proceeds of approximately $9.2 million in a private placement offering from <em style="font: inherit;"> December 2022 </em>through <em style="font: inherit;"> February 2023 </em>with the final closing on <em style="font: inherit;"> February 28, 2023. </em>The Company believes that its existing cash and cash equivalents and financing availability will provide sufficient resources to support operations through the <em style="font: inherit;">second</em> quarter of <em style="font: inherit;">2023.</em> Potentially, the Company could draw down additional funds under the Spectrum Loan Facility; however, its ability to do so is dependent upon the value of eligible accounts receivable assigned to Spectrum as security for advances under the Spectrum Loan Facility, which value fluctuates from time to time and is ultimately outside of the Company’s control. <span style="background-color:#ffffff;">As disclosed in Note <em style="font: inherit;">12,</em> subsequent to <em style="font: inherit;"> March 31, 2023, </em>the Company drew down an additional $1.5 million under the Salem Loan Facility.</span> The Company is also pursuing additional funding opportunities, including planning for a further capital raise in the <em style="font: inherit;">second</em> quarter of <em style="font: inherit;">2023</em> in connection with its planned uplisting to the Nasdaq Stock Market LLC (“Nasdaq”) or another national securities exchange. In the event the Company is unable to secure these or other funding sources, it <em style="font: inherit;"> may </em>be unable to fund ongoing operations and pay its obligations as they become due after the <em style="font: inherit;">second</em> quarter of <em style="font: inherit;">2023.</em></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">As disclosed in Note <em style="font: inherit;">12,</em> in conjunction with the above-noted planned uplisting to the Nasdaq or another national securities exchange, the Company’s board of directors approved a reverse split of shares of the Company’s common stock on a six-for-<em style="font: inherit;">one</em> basis, which was effective as of <em style="font: inherit;">12:01</em> a.m. Eastern Time on <em style="font: inherit;"> April 17, 2023 (</em>the “Effective Time”). As a result of the reverse stock split, at the Effective Time, every <em style="font: inherit;">six</em> shares of the issued and outstanding common stock were automatically converted into <em style="font: inherit;">one</em> share of common stock, but without any change in the par value per share. <em style="font: inherit;">No</em> fractional shares were issued as a result of the reverse stock split. Any fractional shares that would otherwise have resulted from the reverse stock split were rounded up to the next whole number. The number of authorized shares of common stock remains unchanged at 300,000,000 shares. Proportionate adjustments were made to the per share exercise price and the number of shares of common stock issuable upon the exercise of all outstanding stock options and warrants granted by the Company. The number of shares of common stock deliverable upon vesting of restricted stock units were similarly adjusted. Concurrently, the number of shares of common stock reserved for future issuance under the Company’s <em style="font: inherit;">2014</em> and <em style="font: inherit;">2021</em> Equity Incentive Plans immediately prior to the Effective Time were reduced proportionately.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company will require additional funds to respond to business challenges, including developing new solutions or enhancing existing solutions, enhancing our operating infrastructure, expanding our sales and marketing capabilities, and acquiring complementary businesses, technologies, or assets. We plan to engage in additional equity or debt financing to secure the necessary funds; however, equity and debt financing might <em style="font: inherit;">not</em> be available when needed or, if available, might <em style="font: inherit;">not</em> be available on terms satisfactory to us. If we raise additional funds through equity financing, our stockholders <em style="font: inherit;"> may </em>experience dilution. Debt financing, if available, <em style="font: inherit;"> may </em>involve covenants restricting our operations or our ability to incur additional debt. If we are unable to obtain adequate financing or financing on terms satisfactory to us in the future, our ability to continue as a going concern, to support our business growth, and to respond to business challenges could be significantly limited as we <em style="font: inherit;"> may </em>have to delay, reduce the scope of, or eliminate some or all of our initiatives, which could harm our operating results.</p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: left;"/> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b><span style="background-color:#ffffff;">Risks and Uncertainties</span></b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><span style="background-color:#ffffff;">The Company is subject to several risks associated with companies at a similar stage, including dependence on key individuals, competition from similar products and larger companies, volatility of the industry, ability to obtain adequate financing to support growth, the ability to attract and retain additional qualified personnel to manage the anticipated growth of the Company, and general economic conditions including the current macro economic conditions impacting the banking and financial markets.</span></p>
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4000000.0	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-31100000	usd
CY2023Q1	us-gaap	Cash Cash	1900000	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	9200000	usd
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	94667
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	210000
CY2023Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	4.20
CY2023Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	9.42
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt; text-indent: 0pt; text-align: justify;"><b>Use of Estimates</b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The preparation of our unaudited interim condensed consolidated financial statements requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and related disclosures. The preparation of the unaudited interim condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim condensed consolidated financial statements, and reported amounts of revenue and expenses during the reporting period. The Company’s significant estimates and judgments involve the identification of performance obligations in revenue recognition, the valuation of share-based compensation, and the valuation of share-based financing, including the underlying fair value of the common stock. Accordingly, actual results could differ from those estimates.</p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"> </p>
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Concentrations of Credit Risk and Major Customers</b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Financial instruments at <em style="font: inherit;"> March 31, 2023 </em>and <em style="font: inherit;">2022</em> that potentially subject the Company to concentration of credit risk consist primarily of cash and accounts receivable. The Company’s cash is deposited with major financial institutions in the U.S. At times, deposits in financial institutions located in the U.S. <em style="font: inherit;"> may </em>be in excess of the amount of insurance provided on such deposits by the Federal Deposit Insurance Corporation (FDIC). To date, the Company has <em style="font: inherit;">not</em> experienced any losses on its cash deposits.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company’s accounts receivable are derived from revenue earned from customers located in and outside of the U.S. Major customers are defined as those generating revenue in excess of <em style="font: inherit;">10%</em> of the Company’s aggregate annual revenue. The Company had <span style="background-color: rgb(255, 255, 255); font-family: Times New Roman; font-size: 10pt;"><span style="-sec-ix-hidden:c98001686"><span style="-sec-ix-hidden:c98001687">one</span></span> </span>major distributor customer, Richardson RFPD, Inc. ("RFPD") <span style="background-color: rgb(255, 255, 255); font-family: Times New Roman; font-size: 10pt;">accounti</span><span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;">ng for </span></span><span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;">84% and 85% of product shipment revenue</span></span><span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;"> for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> March 31, 2023 </em>and <em style="font: inherit;">2022,</em> respectively. Accounts receivable from RFPD represented 74</span></span><span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;">% and 76% of accounts receivable</span></span><span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;"> at <em style="font: inherit;"> March 31, 2023 </em>and <em style="font: inherit;"> December 31, </em><em style="font: inherit;">2</em></span></span><span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;"><em style="font: inherit;">022,</em></span></span><span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;"> r</span></span><span style="background-color: rgb(255, 255, 255); font-family: Times New Roman; font-size: 10pt;">espectively. </span></p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"> </p>
CY2022Q4	guer	Factoring Agreement Advance Amount Percentage Of Accounts Receivable FactoringAgreementAdvanceAmountPercentageOfAccountsReceivable	0.85	pure
CY2022	guer	Factoring Agreement Receivables Term Oustanding FactoringAgreementReceivablesTermOustanding	P90D
CY2022Q4	guer	Factoring Agreement Percentage Of Receivables Collateral FactoringAgreementPercentageOfReceivablesCollateral	0.15	pure
CY2022Q2	guer	Proceeds From Accounts Receivable Factoring ProceedsFromAccountsReceivableFactoring	3000000	usd
CY2023Q1	guer	Accounts Receivable Secured Debt Facility Receivables Assigned AccountsReceivableSecuredDebtFacilityReceivablesAssigned	1000000.0	usd
CY2023Q1	guer	Accounts Receivable Secured Debt Facility Amount Due AccountsReceivableSecuredDebtFacilityAmountDue	100000	usd
CY2023Q1	guer	Contract With Customer Liability Revenue To Be Recognized ContractWithCustomerLiabilityRevenueToBeRecognized	100000	usd
CY2022Q1	guer	Contract With Customer Liability Revenue To Be Recognized ContractWithCustomerLiabilityRevenueToBeRecognized	0	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0	usd
CY2023Q1	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	6	pure
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6502845
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5538034
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1610975
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	634127
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	0	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	769146
CY2023Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	769146
CY2023Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	0	usd
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	557604	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	696409	usd
CY2023Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	105260	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	44037	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	921051	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	932479	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	1583915	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1672925	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8283171	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7999029	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3299253	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2900932	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4983918	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5098097	usd
CY2023Q1	us-gaap	Depreciation Depreciation	398321	usd
CY2022Q1	us-gaap	Depreciation Depreciation	250937	usd
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	20000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1303176	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	123082	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	88198	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	80389	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	4651988	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	9716	usd
CY2023Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	6256549	usd
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.52	pure
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.67	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0355	pure
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0396	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.74
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.58
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	488721	usd
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	816298	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	601220
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.54
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y10M6D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	9333
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	8.97
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	2863
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	11.41
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	607690
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.60
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y2M4D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	503445
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.40
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y5M19D
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	3200000	usd
CY2023Q1	guer	Sharebased Payment Arrangement Granted Award Option Cost Not Yet Recognized Amount SharebasedPaymentArrangementGrantedAwardOptionCostNotYetRecognizedAmount	500000	usd
CY2023Q1	guer	Sharebased Payment Arrangement Granted Award Cost Not Yet Recognized Period For Recognition SharebasedPaymentArrangementGrantedAwardCostNotYetRecognizedPeriodForRecognition	P2Y9M18D
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y7M9D
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	268640000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	32856000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10896388	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	568000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6388970	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	6956970	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	3851759	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1092101	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2737467	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	3829568	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	296498	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	33257	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	314428	usd
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	163758	usd
CY2023Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	68918	usd
CY2022Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	54905	usd
CY2023Q1	guer	Finance Lease Cost FinanceLeaseCost	383346	usd
CY2022Q1	guer	Finance Lease Cost FinanceLeaseCost	218663	usd
CY2023Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y6M7D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1094	pure
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0709	pure
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	613050	usd
CY2023Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	68600	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	266862	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	997782	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	1314740	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	993973	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	912046	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	121289	usd
CY2023Q1	guer	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	1520	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	4341350	usd
CY2023Q1	guer	Finance Lease Liability Undiscounted Excess Amount Remainder Of Fiscal Year FinanceLeaseLiabilityUndiscountedExcessAmountRemainderOfFiscalYear	183118	usd
CY2023Q1	guer	Finance Lease Liability Undiscounted Excess Amount Next Twelve Months FinanceLeaseLiabilityUndiscountedExcessAmountNextTwelveMonths	177031	usd
CY2023Q1	guer	Finance Lease Liability Undiscounted Excess Amount Year Two FinanceLeaseLiabilityUndiscountedExcessAmountYearTwo	105622	usd
CY2023Q1	guer	Finance Lease Liability Undiscounted Excess Amount Year Three FinanceLeaseLiabilityUndiscountedExcessAmountYearThree	43237	usd
CY2023Q1	guer	Finance Lease Liability Undiscounted Excess Amount Year Four FinanceLeaseLiabilityUndiscountedExcessAmountYearFour	2768	usd
CY2023Q1	guer	Finance Lease Liability Undiscounted Excess Amount After Year Four FinanceLeaseLiabilityUndiscountedExcessAmountAfterYearFour	6	usd
CY2023Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	511782	usd
CY2023Q1	guer	Finance Lease Liability Remainder Of Fiscal Year FinanceLeaseLiabilityRemainderOfFiscalYear	814664	usd
CY2023Q1	guer	Finance Lease Liability Year One FinanceLeaseLiabilityYearOne	1137709	usd
CY2023Q1	guer	Finance Lease Liability Year Two FinanceLeaseLiabilityYearTwo	888351	usd
CY2023Q1	guer	Finance Lease Liability Year Three FinanceLeaseLiabilityYearThree	868809	usd
CY2023Q1	guer	Finance Lease Liability Year Four FinanceLeaseLiabilityYearFour	118521	usd
CY2023Q1	guer	Finance Lease Liability After Year Four FinanceLeaseLiabilityAfterYearFour	1514	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	3829568	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	981111	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1168440	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1087090	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1060174	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1076140	usd
CY2023Q1	guer	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	5986355	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	11359310	usd
CY2023Q1	guer	Lessee Operating Lease Liability Undiscounted Excess Amount Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityUndiscountedExcessAmountRemainderOfFiscalYear	546854	usd
CY2023Q1	guer	Lessee Operating Lease Liability Undiscounted Excess Amount Year One LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearOne	682657	usd
CY2023Q1	guer	Lessee Operating Lease Liability Undiscounted Excess Amount Year Two LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearTwo	631798	usd
CY2023Q1	guer	Lessee Operating Lease Liability Undiscounted Excess Amount Year Three LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearThree	580821	usd
CY2023Q1	guer	Lessee Operating Lease Liability Undiscounted Excess Amount Year Four LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearFour	524555	usd
CY2023Q1	guer	Lessee Operating Lease Liability Undiscounted Excess Amount After Year Four LesseeOperatingLeaseLiabilityUndiscountedExcessAmountAfterYearFour	1435655	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4402340	usd
CY2023Q1	guer	Operating Lease Liability Remainder Of Fiscal Year OperatingLeaseLiabilityRemainderOfFiscalYear	434257	usd
CY2023Q1	guer	Operating Lease Liability Year One OperatingLeaseLiabilityYearOne	485783	usd
CY2023Q1	guer	Operating Lease Liability Year Two OperatingLeaseLiabilityYearTwo	455292	usd
CY2023Q1	guer	Operating Lease Liability Year Three OperatingLeaseLiabilityYearThree	479353	usd
CY2023Q1	guer	Operating Lease Liability Year Four OperatingLeaseLiabilityYearFour	551585	usd
CY2023Q1	guer	Operating Lease Liability After Year Four OperatingLeaseLiabilityAfterYearFour	4550700	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	6956970	usd
CY2023Q1	guer	Lessee Operating Lease Lease Not Yet Commenced Annual Lease Expense LesseeOperatingLeaseLeaseNotYetCommencedAnnualLeaseExpense	1500000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q1	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.04	pure
CY2023Q1	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	89636	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	79234	usd

Files In Submission

Name	View Source	Status
0001437749-23-013411-index-headers.html	Edgar Link	pending
0001437749-23-013411-index.html	Edgar Link	pending
0001437749-23-013411.txt	Edgar Link	pending
0001437749-23-013411-xbrl.zip	Edgar Link	pending
ex_491259.htm	Edgar Link	pending
ex_491260.htm	Edgar Link	pending
ex_491261.htm	Edgar Link	pending
ex_491262.htm	Edgar Link	pending
ex_513776.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
guer-20230331.xsd	Edgar Link	pending
guer20230331_10q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
guer-20230331_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
guer-20230331_pre.xml	Edgar Link	unprocessable
guer-20230331_def.xml	Edgar Link	unprocessable
guer-20230331_lab.xml	Edgar Link	unprocessable
guer20230331_10q_htm.xml	Edgar Link	completed
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GUER
Guerrilla RF Inc Stock $guer

2023 Q2 Form 10-Q Financial Statement

#000143774923013411 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GUER Guerrilla RF Inc Stock $guer

2023 Q2 Form 10-Q Financial Statement

#000143774923013411 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GUER
Guerrilla RF Inc Stock $guer